The global lymphopenia therapeutics market at a CAGR of almost 4% during the forecast period

NEXT STORY
Ziopharm Oncology Names Drug Development Leader Dr. Chris Bowden to Board of Directors
PREV STORY
The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AVRA Medical Robotics, Inc. issues CEO letter to Shareholders

ORLANDO, Fla., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Avra Medical Robotics, Inc. (OTCQB: AVMR) ...

author_avatar
NASDAQ Market News

Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients

79% of patients felt uncomfortable raising psychological and emotional concerns during their consultations1Disease recurrence ...

author_avatar
NASDAQ Market News

Celyad Receives the First US Patent Covering a Method of Producing Allogeneic TCR-Deficient CAR T-Cells

MONT-SAINT-GUIBERT, Belgium, March 02, 2016 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a ...

author_avatar
NASDAQ Market News